Alum-GAD
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Alum-GAD, covering 2020-10-27 to 2020-10-27. Get the full timeline:
Most recent: Clinical Trial Update: Prevention Trial: Immune-tolerance With Alum-GAD (Diamyd) and Vitamin D3 to Children With Multiple Islet Autoantibodies [Phase 2]